The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-cyclopentyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(4-(morpholinomethyl)phenyl)indoline-4-carboxamide ID: ALA3923183
PubChem CID: 134139550
Max Phase: Preclinical
Molecular Formula: C34H42N4O3
Molecular Weight: 554.74
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C)c(CNC(=O)c2cc(-c3ccc(CN4CCOCC4)cc3)cc3c2C(C)CN3C2CCCC2)c(=O)[nH]1
Standard InChI: InChI=1S/C34H42N4O3/c1-22-16-24(3)36-34(40)30(22)19-35-33(39)29-17-27(18-31-32(29)23(2)20-38(31)28-6-4-5-7-28)26-10-8-25(9-11-26)21-37-12-14-41-15-13-37/h8-11,16-18,23,28H,4-7,12-15,19-21H2,1-3H3,(H,35,39)(H,36,40)
Standard InChI Key: QHNITKGBPYIHKK-UHFFFAOYSA-N
Molfile:
RDKit 2D
41 46 0 0 0 0 0 0 0 0999 V2000
14.0667 -10.8511 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.5324 -10.1800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0382 -9.5292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2657 -9.8019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5513 -9.4093 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8522 -9.8294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8718 -10.6463 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5862 -11.0430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2853 -10.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5317 -8.5924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8132 -8.1956 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.2308 -8.1640 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1727 -11.0705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4541 -10.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7592 -11.1063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7746 -11.9231 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4932 -12.3117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1922 -11.8874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0797 -12.3474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9280 -11.1695 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9434 -11.9864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6620 -12.3790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3611 -11.9548 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3416 -11.1379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6271 -10.7453 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2746 -8.7478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2113 -7.3471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8908 -6.1060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9103 -6.9229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6289 -7.3155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3280 -6.8913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3084 -6.0744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5898 -5.6818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.1763 -5.7134 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0075 -5.6501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6443 -8.1324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3394 -11.6235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8737 -12.2946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3679 -12.9454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1403 -12.6768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1208 -11.8599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
1 9 1 0
4 9 2 0
10 11 2 0
10 12 1 0
5 10 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
13 18 2 0
20 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
20 25 1 0
19 23 1 0
16 19 1 0
7 13 1 0
3 26 1 0
28 29 1 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
28 33 1 0
28 34 2 0
32 35 1 0
30 36 1 0
27 29 1 0
12 27 1 0
37 38 1 0
38 39 1 0
39 40 1 0
40 41 1 0
37 41 1 0
1 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 554.74Molecular Weight (Monoisotopic): 554.3257AlogP: 5.29#Rotatable Bonds: 7Polar Surface Area: 77.67Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.64CX Basic pKa: 7.19CX LogP: 4.38CX LogD: 4.17Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.42Np Likeness Score: -1.04
References 1. Ansari A, Satalkar S, Patil V, Shete AS, Kaur S, Gupta A, Singh S, Raja M, Severance DL, Bernales S, Chakravarty S, Hung DT, Pham SM, Herrera FJ, Rai R.. (2017) Novel 3-methylindoline inhibitors of EZH2: Design, synthesis and SAR., 27 (2): [PMID:27923618 ] [10.1016/j.bmcl.2016.11.080 ] 2. Ansari A, Satalkar S, Patil V, Shete AS, Kaur S, Gupta A, Singh S, Raja M, Severance DL, Bernales S, Chakravarty S, Hung DT, Pham SM, Herrera FJ, Rai R.. (2017) Novel 3-methylindoline inhibitors of EZH2: Design, synthesis and SAR., 27 (2): [PMID:27923618 ] [10.1016/j.bmcl.2016.11.080 ]